Enhanced Parasitology Facility at Charles River IrelandMore Choice, Increased Capacity, Quicker Results
June 8, 2011 - Charles River is delighted to announce the expansion of our parasitology facility in the West of Ireland. Our fully validated, custom-built and energy-efficient facility of approximately 6,000 sq. ft. provides a significant increase in our capacity for tick production (EU and US strains). In addition, it allows us to expand into new species, such as sandflies and mosquitoes.
Charles River has over 30 years of experience providing solutions to the animal health industry in ectoparasitology and endoparasitology. With this development, we can now offer not only an extended range of species, but also larger study designs and improved scheduling to meet your program requirements.
Through our rapid in vitro screening service, our colonies of fleas and several species of ticks can be used to evaluate the potential of new candidate molecules. In addition, we can breed ectoparasites common to livestock species and companion animals.
Our range of study designs includes efficacy studies for both endo- and ectoparasite species, as well as the full range of regulatory studies. Regulatory studies include safety/tolerance, reproductive safety, pharmacokinetics and residue analysis - all of which meet FDA, US EPA, European EMA and VICH guidelines.
For more information about our enhanced parasitology facility or services, please contact us at 1.877.CRIVER.1 or email email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
We have established an in vivo screening platform to provide fast and cost-effective screening of compound effects on motor behavior and brain functionality for the study for central nervous system diseases.
We offer a package of well-established, state of the art in vitro mode of action assays that are suitable for early phase biocomparability studies, lot release and stability. These tests can accelerate the time it takes to get a new product ready for market submission.
May 21–May 24
RDD Europe 2013 is a forum for pulmonary and nasal drug delivery experts from all around the world to exchange scientific knowledge and expertise.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.